版本:
中国

BRIEF-Sage Therapeutics initiates phase 1 single ascending dose trial

April 27 Sage Therapeutics Inc:

* Sage Therapeutics - initiated phase 1 single ascending dose (SAD) trial of sage-718; top-line results from sad study are expected in 2H of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐